Xu H, Liu Y. ROS-responsive nanomodulators downregulate IFITM3 expression and eliminate ROS for Alzheimer's disease combination treatment. J Colloid Interface Sci. 2023 Sep;645:210-218. Epub 2023 May 2 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.